SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

Dylan Lewis: We're talking three stocks down bad. Motley Fool Money starts down. I'm Dylan Lewis, I'm joined over the ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, personal finance education, top-rated podcasts, and ...

Investing in under-the-radar stocks can be a savvy move for those ... The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week.

Biotech has lagged even more. The S&P Biotechnology Select Industry Index has returned about 3 per cent annually over 10 ...

Shares of Trump Media & Technology Group ( DJT ), which owns the Truth Social platform, were recently down 10% at about $36. They’ve mostly fallen since touching January highs above $40 and ...